CN112972361B - Composition, preparation method thereof and anti-aging cosmetic - Google Patents
Composition, preparation method thereof and anti-aging cosmetic Download PDFInfo
- Publication number
- CN112972361B CN112972361B CN202110320424.6A CN202110320424A CN112972361B CN 112972361 B CN112972361 B CN 112972361B CN 202110320424 A CN202110320424 A CN 202110320424A CN 112972361 B CN112972361 B CN 112972361B
- Authority
- CN
- China
- Prior art keywords
- component
- skin
- mass
- aging
- cosmetic composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 59
- 230000003712 anti-aging effect Effects 0.000 title claims abstract description 36
- 239000002537 cosmetic Substances 0.000 title claims abstract description 34
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- 239000000419 plant extract Substances 0.000 claims abstract description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 49
- 238000000855 fermentation Methods 0.000 claims description 45
- 230000004151 fermentation Effects 0.000 claims description 45
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 241000143476 Bidens Species 0.000 claims description 15
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 13
- 244000104272 Bidens pilosa Species 0.000 claims description 13
- 235000010662 Bidens pilosa Nutrition 0.000 claims description 13
- 235000019482 Palm oil Nutrition 0.000 claims description 13
- 235000010445 lecithin Nutrition 0.000 claims description 13
- 239000000787 lecithin Substances 0.000 claims description 13
- 229940067606 lecithin Drugs 0.000 claims description 13
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 13
- 239000002540 palm oil Substances 0.000 claims description 13
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 13
- 235000021388 linseed oil Nutrition 0.000 claims description 11
- 239000000944 linseed oil Substances 0.000 claims description 11
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims description 8
- 239000001963 growth medium Substances 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 240000004082 Bidens tripartita Species 0.000 claims description 7
- 235000000621 Bidens tripartita Nutrition 0.000 claims description 7
- 244000025254 Cannabis sativa Species 0.000 claims description 7
- 238000001816 cooling Methods 0.000 claims description 7
- 239000002385 cottonseed oil Substances 0.000 claims description 7
- 235000012343 cottonseed oil Nutrition 0.000 claims description 7
- -1 dimethyl taurate Chemical compound 0.000 claims description 7
- 150000004676 glycans Chemical class 0.000 claims description 7
- 238000009630 liquid culture Methods 0.000 claims description 7
- 229920001282 polysaccharide Polymers 0.000 claims description 7
- 239000005017 polysaccharide Substances 0.000 claims description 7
- 241000223678 Aureobasidium pullulans Species 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 5
- 241000186660 Lactobacillus Species 0.000 claims description 5
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 5
- 229910001424 calcium ion Inorganic materials 0.000 claims description 5
- 229940039696 lactobacillus Drugs 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 5
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 5
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims description 4
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 claims description 4
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 4
- 241000382840 Hyriopsis cumingii Species 0.000 claims description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- 229920001202 Inulin Polymers 0.000 claims description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims description 4
- 241000233805 Phoenix Species 0.000 claims description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 4
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 claims description 4
- 229960003237 betaine Drugs 0.000 claims description 4
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 claims description 4
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 4
- CNRDTAOOANTPCG-UHFFFAOYSA-N dodecyl carbamate Chemical compound CCCCCCCCCCCCOC(N)=O CNRDTAOOANTPCG-UHFFFAOYSA-N 0.000 claims description 4
- 229940089468 hydroxyethylpiperazine ethane sulfonic acid Drugs 0.000 claims description 4
- 229940029339 inulin Drugs 0.000 claims description 4
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 4
- 229960005323 phenoxyethanol Drugs 0.000 claims description 4
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- 229940104261 taurate Drugs 0.000 claims description 4
- 241000498884 Bidens alba Species 0.000 claims description 3
- 241000490567 Pinctada Species 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 210000000582 semen Anatomy 0.000 claims description 2
- 241000196324 Embryophyta Species 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 239000003921 oil Substances 0.000 claims 1
- 235000019198 oils Nutrition 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 241000894007 species Species 0.000 claims 1
- 230000037303 wrinkles Effects 0.000 abstract description 17
- 230000001737 promoting effect Effects 0.000 abstract description 16
- 210000002950 fibroblast Anatomy 0.000 abstract description 13
- 230000035755 proliferation Effects 0.000 abstract description 11
- 230000037394 skin elasticity Effects 0.000 abstract description 10
- 230000036572 transepidermal water loss Effects 0.000 abstract description 9
- 206010013786 Dry skin Diseases 0.000 abstract description 5
- 241000217407 Margaritifera Species 0.000 abstract description 3
- 230000003679 aging effect Effects 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 53
- 230000000694 effects Effects 0.000 description 21
- 238000012360 testing method Methods 0.000 description 18
- 235000011187 glycerol Nutrition 0.000 description 14
- 239000002502 liposome Substances 0.000 description 11
- 210000000434 stratum corneum Anatomy 0.000 description 9
- 230000001815 facial effect Effects 0.000 description 8
- 230000032683 aging Effects 0.000 description 7
- 239000000284 extract Substances 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 6
- 235000015112 vegetable and seed oil Nutrition 0.000 description 5
- 239000009606 Bidens pilosa plant extract Substances 0.000 description 4
- 240000002024 Gossypium herbaceum Species 0.000 description 4
- 235000004341 Gossypium herbaceum Nutrition 0.000 description 4
- 230000004663 cell proliferation Effects 0.000 description 4
- 231100001083 no cytotoxicity Toxicity 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 210000004207 dermis Anatomy 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 206010067484 Adverse reaction Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 241001212699 Pinctada martensii Species 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 230000036548 skin texture Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- 238000009631 Broth culture Methods 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241000382825 Cristaria plicata Species 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001303775 Phlomis Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 238000007427 paired t-test Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 210000001626 skin fibroblast Anatomy 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
The invention relates to the technical field of skin external preparations, in particular to a composition, a preparation method thereof and an anti-aging cosmetic. The composition comprises the following components in percentage by mass; 25 to 35 percent of component A and 65 to 75 percent of component B; the component A comprises herba Bidentis Bipinnatae plant extract, and the component B comprises Concha Margaritifera fermented product. The composition has excellent fibroblast proliferation promoting activity and excellent anti-primary aging effect through the coordination and coordination of the components. The anti-aging cosmetic prepared from the composition has good anti-aging effect, and can remarkably reduce skin wrinkles, increase the moisture content of skin horny layer, reduce skin roughness, smoothen skin, increase skin elasticity and reduce transepidermal water loss after being used.
Description
Technical Field
The invention relates to the technical field of skin external preparations, in particular to a composition, a preparation method thereof and an anti-aging cosmetic.
Background
The market scale of the anti-aging products shows a continuous acceleration trend from 2016, and according to statistics, the population proportion of the most active target user group of the anti-aging products between 25 and 49 years is gradually increased. In young consumers of 20-25 years old, some common skin aging manifestations such as dull and dull skin, insufficient skin moisture and the like begin to be concerned. Research shows that the skin gradually enters a natural aging state from the age of 20-25, and the aging speed is different according to different genetic genes and living habits of each person. Due to the influence of factors such as fast-paced life, night stay, working pressure and the like, the early-aged appearance of the skin of a part of young consumers in the age of more than 20 years is obvious, including dry and tight skin; facial laxity with slight sagging; fine lines appear on eyes; neck lines appear; slow recovery rate after tanning, etc. The anti-aging is to make various anti-aging works at the early stage of skin aging to delay the natural aging speed.
Human skin is composed of epidermis, basement membrane and dermis, and fibroblasts in the dermis layer have the effects of producing collagen, elastin, glycosaminoglycan and the like, and the components have the effects of maintaining skin elasticity, moisturizing the dermis layer and the like. The activity of fibroblasts plays a crucial role in maintaining the healthy appearance of skin. It has been observed that with age, the proliferation of fibroblasts and the functional activity of synthesizing skin benefit agents gradually decrease. In the past, the fibroblast activity of old skin is improved by increasing the dosage of cell activity stimulator; there are different needs for improvement of the initial aging symptoms of young skin, and the method of increasing the amount of the irritant is not completely suitable for the initial aging skin.
In view of the above, the present invention is particularly proposed.
Disclosure of Invention
The invention aims to provide a composition which has excellent activity of promoting fibroblast proliferation and good anti-primary-aging effect through the coordinated cooperation of the components.
The invention also aims to provide a preparation method of the composition, which is simple to operate and environment-friendly.
It is another object of the present invention to provide an anti-aging cosmetic composition having excellent anti-aging effects, which can significantly reduce skin wrinkles, increase the moisture content of the stratum corneum of the skin, reduce skin roughness, smooth the skin, increase skin elasticity, and reduce transepidermal water loss after use.
In order to achieve the above purpose of the present invention, the following technical solutions are adopted:
the composition comprises the following components in percentage by mass;
25 to 35 percent of component A and 65 to 75 percent of component B;
the component A comprises herba Bidentis Bipinnatae plant extract, and the component B comprises Concha Margaritifera fermented product.
Preferably, the component A comprises the following components in percentage by mass:
10-20% of bidens extract, 10-15% of lecithin, 40-60% of glycerol, 10-15% of caprylic/capric triglyceride, 1-10% of palm oil, 1-10% of grass cotton seed oil and 1-5% of linseed oil.
Preferably, the component A also comprises 0.1 to 10 percent of water by mass percentage.
Preferably, the bidens plant is selected from at least one of bidens pilosa, bidens salicifolia, bidens tripartita and bidens alba, and is preferably bidens pilosa.
Preferably, the mother-of-pearl fermentation product is mainly prepared by fermenting strains and mother-of-pearl, wherein the strains are selected from at least one of yeast, aureobasidium pullulans and lactobacillus;
preferably, in the mother-of-pearl fermentation product, the content of polysaccharide is 30-300 mg/L, and the content of calcium ions is 10-200 mg/L;
preferably, the mother-of-pearl is selected from at least one of the group consisting of a queen phoenix, a hyriopsis cumingii, a crista plicata and a pearl oyster of mad.
A process for the preparation of a composition as described above, comprising the steps of:
and uniformly mixing the component A and the component B.
Preferably, the preparation method of the component A comprises the following steps:
adding the lecithin into the mixture of the Bidens plant extract, the caprylic/capric triglyceride, the grass cotton seed oil, the linseed oil and the palm oil, heating, adding the glycerol and the water, homogenizing and cooling.
Preferably, the preparation method of the mother-of-pearl fermentation product comprises the following steps:
inoculating the strain into the mixture of the crushed nacre and the fermentation liquid culture medium, and performing fermentation culture;
preferably, the addition amount of the crushed nacre is 0.01-10% of the mass of the fermentation liquid culture medium;
preferably, the culture temperature is 27.8-28.2 ℃, and the culture time is 4-6 days;
preferably, the culture is shaking culture, and the rotation speed of the culture is 115-125 rpm.
An anti-aging cosmetic comprising the composition as described above;
preferably, the dosage of the composition is 0.001-10%, preferably 0.01-5% of the total mass of the anti-aging cosmetic.
Preferably, the anti-aging cosmetic comprises essence;
preferably, the essence is mainly prepared from the following components in percentage by mass:
0.1-2% of sodium polyacryloyl dimethyl taurate, 0.5-5% of diglycerol, 1-10% of glycerol, 0.5-5% of betaine, 0.1-4% of hydroxyethyl piperazine ethane sulfonic acid, 0.01-1% of acetylated sodium hyaluronate, 0.01-0.5% of inulin lauryl carbamate, 0.1-2% of octyl dodecanol, 0.2-10% of polydimethylsiloxane, 0.1-10% of the composition, 0.1-0.5% of p-hydroxyacetophenone, 0.1-0.5% of phenoxyethanol, 0.01-0.02% of essence and the balance of water.
Compared with the prior art, the invention has the beneficial effects that:
(1) the composition has excellent fibroblast proliferation promoting activity and good anti-aging effect through the coordination and coordination of the components.
(2) The preparation method of the composition is simple to operate.
(3) The anti-aging cosmetic disclosed by the invention has a good anti-aging effect, and can obviously reduce skin wrinkles, increase the moisture content of the horny layer of the skin, reduce the skin roughness, smoothen the skin, increase the skin elasticity and reduce the transepidermal water loss after being used.
Detailed Description
Embodiments of the present invention will be described in detail below with reference to examples, but it will be understood by those skilled in the art that the following examples are only illustrative of the present invention and should not be construed as limiting the scope of the present invention. The examples, in which specific conditions are not specified, were conducted under conventional conditions or conditions recommended by the manufacturer. The reagents or instruments used are not indicated by the manufacturer, and are all conventional products commercially available.
According to one aspect of the invention, the invention relates to a composition, comprising the following components in percentage by mass;
component A25% -35% and component B65% -75%;
the component A comprises herba Bidentis Bipinnatae plant extract, and the component B comprises Concha Margaritifera fermented product.
The herba Bidentis Bipinnatae plant extract contains flavone and volatile oil, and has effects of clearing away heat and toxic materials, removing blood stasis, promoting blood circulation, whitening skin, and repairing tissue.
The nacre is the nacre layer of shells of shellfish, and common sources include hyriopsis cumingii, crista plicata, and Pinctada martensii, and the more rare Queen Phoenix shell producing a pearl. The mother-of-pearl comprises the following main components: 1) calcium: the main factors regulating nerves and muscles participate in various metabolisms in the body and are also the components of bones; 2) trace elements: contains higher lithium and magnesium elements; 3) amino acids: contains more than twenty kinds of amino acids, mainly including aspartic acid, threonine, serine, glycine and alanine; 4) a polysaccharide.
The composition has the advantages of promoting the proliferation activity of fibroblast, having good safety and no cytotoxicity by the coordination of the extract of the bidens and the fermentation product of the nacre.
In one embodiment, the component a is 25% to 35%, and may alternatively be 25%, 26%, 27%, 28%, 29%, 30%, 31%, 32%, 33%, 34%, or 35%.
In one embodiment, the component B is 65% to 75%, and may alternatively be 65%, 66%, 67%, 68%, 69%, 70%, 71%, 72%, 73%, 74%, or 75%.
Preferably, the component A comprises the following components in percentage by mass:
10-20% of bidens extract, 10-15% of lecithin, 40-60% of glycerol, 10-15% of caprylic/capric triglyceride, 1-10% of palm oil, 1-10% of grass cotton seed oil and 1-5% of linseed oil.
The components are coordinated and matched, so that the composition has a better effect of promoting fibroblast proliferation and has an excellent anti-aging effect.
In one embodiment, in the component a, the content of the bidens extract is 10% to 20% by mass, and may be 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19% or 20% by mass.
In one embodiment, the content of lecithin in the component a is 10% to 15% by mass, and may be 10%, 11%, 12%, 13%, 14% or 15% by mass.
In one embodiment, the content of glycerin in the component a is 40% to 60% by mass, and may also be selected from 40%, 41%, 42%, 43%, 44%, 45%, 46%, 47%, 48%, 49%, 50%, 51%, 52%, 53%, 54%, 55%, 56%, 57%, 58%, 59% or 60%.
In one embodiment, the content of the caprylic/capric triglyceride in the component a is 10% to 15% by mass, and may be 10%, 11%, 12%, 13%, 14% or 15% by mass.
In one embodiment, the amount of the palm oil in the component a is 1% to 10% by mass, and may be 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9% or 10% by mass.
In one embodiment, in the component a, the content of the gossypium herbaceum seed oil is 1% to 10% by mass, and may be 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9% or 10% by mass.
In one embodiment, in the component a, the linseed oil accounts for 1% to 5% by mass, and may also be selected from 1%, 2%, 3%, 4% or 5%.
Preferably, the component A also comprises 0.1 to 10 percent of water by mass percentage.
In one embodiment, the component a further includes 0.1% to 10% by mass of water, and may further include 0.1%, 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, or 10% by mass.
Preferably, the bidens plant is selected from at least one of bidens pilosa, bidens salicifolia, bidens tripartita and bidens alba, and is preferably bidens pilosa.
The invention adds proper amount of bidens pilosa extract, and has at least the following excellent effects: clearing away heat and toxic material, removing blood stasis, promoting blood circulation, whitening skin, and repairing tissue.
The bidens tripartita contains components such as flavonoid, tannin, polysaccharide, amino acid, ascorbic acid, organic acid and the like, and has remarkable anti-inflammatory, analgesic and antipyretic activities.
Preferably, the mother-of-pearl fermentation product is mainly prepared by fermenting a strain and mother-of-pearl, wherein the strain is at least one of yeast, aureobasidium pullulans and lactobacillus.
The invention selects at least one of yeast, aureobasidium pullulans and lactobacillus as a fermentation strain, and the fermentation strain is mixed with the mother-of-pearl for fermentation, so that the obtained mother-of-pearl fermentation product can further improve the activity of the effective components, and can further promote the skin fibroblast proliferation and the anti-primary aging activity by matching with the bidens plant extract.
Preferably, in the mother-of-pearl fermentation product, the content of polysaccharide is 30-300 mg/L, and the content of calcium ions is 10-200 mg/L;
preferably, the mother-of-pearl is selected from at least one of the group consisting of a queen phoenix, a hyriopsis cumingii, a crista plicata and a pearl oyster of mad.
According to another aspect of the invention, the invention also relates to a process for the preparation of said composition, comprising the steps of:
and uniformly mixing the component A and the component B.
The preparation process is simple and feasible.
Preferably, the preparation method of the component A comprises the following steps:
adding the lecithin into the mixture of the Bidens plant extract, the caprylic/capric triglyceride, the grass cotton seed oil, the linseed oil and the palm oil, heating, adding the glycerol and the water, homogenizing and cooling.
The component A prepared by the method is uniformly mixed, and can be better coordinated with the mother-of-pearl fermentation product to play the role of primary aging resistance.
Preferably, the preparation method of the mother-of-pearl fermentation product comprises the following steps:
inoculating the strain into the mixture of the crushed nacre and the fermentation liquid culture medium, and performing fermentation culture.
Preferably, the addition amount of the crushed nacre is 0.01-10% of the mass of the fermentation liquid culture medium;
preferably, the temperature of the culture is 27.8-28.2 ℃, and the time of the culture is 4-6 days.
Preferably, the culture is shaking culture, and the rotation speed of the culture is 115-125 rpm.
In one embodiment, the temperature of the culture is 27.8-28.2 ℃, and can be 27.8 ℃, 27.9 ℃, 28 ℃, 28.1 ℃ or 28.2 ℃.
In one embodiment, the culturing time is 4-6 days, and further 4 days, 5 days or 6 days can be selected.
In one embodiment, the rotation speed of the culture is 115-125 rpm, and 115rpm, 116rpm, 117rpm, 118rpm, 119rpm, 120rpm, 121rpm, 122rpm, 123rpm, 124rpm or 125rpm can be selected.
According to another aspect of the invention, the invention also relates to an anti-aging cosmetic comprising a composition as described above.
Preferably, the dosage of the composition is 0.001-10%, preferably 0.01-5% of the total mass of the anti-aging cosmetic.
In one embodiment, the amount of the composition is 0.001% to 10% of the total weight of the anti-aging cosmetic, and may be 0.001%, 0.1%, 0.5%, 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, or 10%.
Preferably, the anti-aging cosmetic comprises essence;
preferably, the essence is mainly prepared from the following components in percentage by mass:
0.1-2% of sodium polyacryloyl dimethyl taurate, 0.5-5% of diglycerol, 1-10% of glycerol, 0.5-5% of betaine, 0.1-4% of hydroxyethyl piperazine ethane sulfonic acid, 0.01-1% of acetylated sodium hyaluronate, 0.01-0.5% of inulin lauryl carbamate, 0.1-2% of octyl dodecanol, 0.2-10% of polydimethylsiloxane, 0.1-10% of the composition, 0.1-0.5% of p-hydroxyacetophenone, 0.1-0.5% of phenoxyethanol, 0.01-0.02% of essence and the balance of water.
Preferably, the essence further comprises a proper amount of preservative and essence.
The present invention will be further explained with reference to specific examples and comparative examples.
Example 1
The composition consists of the following components in percentage by mass;
30% of component A and 70% of component B;
the component A comprises the following components in percentage by mass: bidens pilosa extract 15%, lecithin 12%, glycerin 50%, caprylic/capric triglyceride 13%, palm oil 5%, gossypium herbaceum seed oil 3%, linseed oil 2 and water 5%;
the component B is mother-of-pearl fermentation product;
the preparation method of the composition comprises the following steps:
(a) preparation of component a (bidens pilosa liposomes): stirring herba Bidentis Tripartitae extract, caprylic/capric triglyceride, palm oil, semen gossypii seed oil and oleum Lini at room temperature to disperse uniformly, adding lecithin dissolved by heating and stirring, mixing uniformly, heating, adding glycerol and water, homogenizing, and cooling to room temperature to obtain yellowish viscous liquid herba Bidentis Tripartitae liposome;
(b) preparing mother-of-pearl fermentation: removing horny layer of the Phlomis emarginata, reserving a pearl layer, crushing to prepare micron-sized powder, adding the micron-sized powder into a fermentation liquid culture medium according to a proportion of 0.2%, inoculating aureobasidium pullulans liquid after sterilization, placing the inoculated aureobasidium pullulans liquid on a constant temperature shaking table, fermenting and culturing for 5 days at 28 ℃, 120rpm, and after the fermentation is finished, dissolving bacteria, decolorizing and filtering to obtain mother-of-pearl fermentation product, wherein the polysaccharide content is 30mg/L, and the calcium ion content is 10 mg/L;
(c) sequentially adding the component A obtained in the step (a) and the mother-of-pearl fermentation product obtained in the step (b) into a stirring kettle, stirring at a low speed until the components are uniformly mixed, and cooling to room temperature.
Example 2
The composition consists of the following components in percentage by mass;
35% of component A and 65% of component B;
the component A comprises the following components in percentage by mass: 10% of bidens pilosa extract, 15% of lecithin, 40% of glycerol, 15% of caprylic/capric triglyceride, 1% of palm oil, 1% of gossypium herbaceum seed oil, 5% of linseed oil and 3% of water;
the component B is mother-of-pearl fermentation product;
the composition was prepared as in example 1.
Example 3
The composition consists of the following components in percentage by mass;
25% of component A and 75% of component B;
the component A comprises the following components in percentage by mass: 20% of bidens pilosa extract, 10% of lecithin, 55% of glycerol, 10% of caprylic/capric triglyceride, 1% of palm oil, 1% of gossypium herbaceum seed oil, 1% of linseed oil and 2% of water;
the component B is mother-of-pearl fermentation product;
the composition was prepared as in example 1.
Example 4
The composition consists of the following components in percentage by mass;
30% of component A and 70% of component B;
the component A comprises the following components in percentage by mass: 15% of bidens tripartita extract, 12% of lecithin, 50% of glycerol, 13% of caprylic/capric triglyceride, 5% of palm oil, 3% of grass cotton seed oil, 2% of linseed oil and 5% of water;
the component B is mother-of-pearl fermentation product;
the preparation method of the composition comprises the following steps:
(a) preparation of component a (tripartite liposome): stirring the bidens tripartita extract, caprylic/capric triglyceride, palm oil, grass cotton seed oil and linseed oil at room temperature until the mixture is uniformly dispersed, adding lecithin which is heated and stirred to be dissolved, uniformly mixing, heating, adding glycerol and water, homogenizing, and cooling to room temperature to obtain a yellow viscous liquid bidens tripartita liposome;
(b) preparing mother-of-pearl fermentation: removing horny layer of Cristaria plicata and Pinctada martensii (mass ratio of 1:1), retaining pearl layer, crushing to obtain micron-sized powder, adding into fermentation broth culture medium according to 0.2%, sterilizing, inoculating lactobacillus, placing on a constant temperature shaking table, fermenting and culturing at 28 deg.C and 125rpm for 4 days, after fermentation, dissolving bacteria, decolorizing and filtering to obtain mother-of-pearl fermentation product, wherein polysaccharide content is 50mg/L, and calcium ion content is 20 mg/L;
(c) sequentially adding the component A obtained in the step (a) and the mother-of-pearl fermentation product obtained in the step (b) into a stirring kettle, stirring at a low speed until the components are uniformly mixed, and cooling to room temperature.
Example 5
The anti-aging essence is mainly prepared from the following components in percentage by mass:
0.6% of sodium polyacryloyldimethyl taurate, 2% of diglycerol, 4% of glycerol, 2% of betaine, 0.8% of hydroxyethyl piperazine ethanesulfonic acid, 0.1% of acetylated sodium hyaluronate, 0.01% of sodium hyaluronate, 0.1% of inulin lauryl carbamate, 0.2% of octyldodecanol, 1% of polydimethylsiloxane, 0.5% of the composition, 0.25% of p-hydroxyacetophenone, 0.15% of phenoxyethanol, 0.02% of essence, and the balance of water.
Examples of the experiments
Fibroblast activity promoting effect
3T3 cells in logarithmic growth phase were seeded in 96-well plates and placed in CO2After 3 days of incubator culture, cells were treated with a series of different samples of different concentrations, solvent blank and positive control were set, CO was added2After the incubator is incubated for 24 hours, 0.5mg/mL MTT is added for continuous culture for 4 hours, 100 mu L DMSO is added, and an enzyme-labeling instrument is used for detecting OD550 and carrying out statistical analysis; the results are shown in Table 1.
TABLE 1 fibroblast Activity-promoting Effect test results
| Sample name | Concentration of | Cell viability (%) |
| NT | / | 100±5.6 |
| Positive control | / | 115.1±3.3 |
| Bidens pilosa liposomes of example 1 | 0.001％ | 101.5±4.5 |
| Bidens pilosa liposomes of example 1 | 0.005％ | 100.8±5.4 |
| Bidens pilosa liposomes of example 1 | 0.01％ | 103.7±4.6 |
| Bidens pilosa liposomes of example 1 | 0.05％ | 98.3±0.1 |
| Mother-of-pearl fermentation product of example 1 | 0.001％ | 96.8±5.2 |
| Mother-of-pearl fermentation product of example 1 | 0.005％ | 114.6±12.1 |
| Mother-of-pearl fermentation product of example 1 | 0.01％ | 113.0±12.1 |
| Mother-of-pearl fermentation product of example 1 | 0.05％ | 116.6±7.1 |
| Composition of example 1 | 0.001％ | 122.0±19.9 |
| Composition of example 1 | 0.005％ | 126.6±6.6 |
| Composition of example 1 | 0.01％ | 128.9±13.1 |
| Composition of example 1 | 0.05％ | 123.1±7.5 |
As shown in Table 1, in comparison with NT group, Bidens pilosa liposome has no cytotoxicity in the concentration range of 0.05% -0.001%, and has slight but not obvious effect of promoting fibroblast proliferation, and the maximum effect of promoting cell proliferation is 103.7%. Compared with NT group, the fermentation product of nacre has no cytotoxicity in the concentration range of 0.05-0.001%, and has certain effect of promoting the proliferation of fiber cells, the maximum effect of promoting the proliferation of cells is 116.6%. The active composition of the external anti-aging skin preparation prepared in example 3 has no cytotoxicity in the concentration range of 0.05% -0.001%, and has strong fibroblast proliferation promoting effect, and the effect values of promoting cell proliferation under the same concentration are all higher than those of the individual bidens pilosa liposome and the mother-of-pearl fermentation product, which shows that the compound of the bidens pilosa liposome and the mother-of-pearl fermentation product has obvious cell proliferation promoting effect, and the cell proliferation promoting effect is superior to that of the two when acting on cells alone.
Second, evaluation of anti-aging ability
The essence prepared in example 5 was subjected to a test of the aging resistance before and after use.
Volunteers: female aged 27-50 years; the moisture value of the cheek is less than or equal to 60c.u., the canthus wrinkles are more than or equal to grade 1, and the facial skin is rough; actually recruiting 33 people, valid data 33 people;
test area: a face;
the using method comprises the following steps: the volunteers use the liquid once in the morning and at night every day, and 0.8-1 g of 2 dropper essence liquid is uniformly smeared on the whole face until the liquid is absorbed;
the service cycle is as follows: 28 days;
frequency of use: the medicine is used once in the morning and at night;
and (3) testing period: before use, 14 days after use, 28 days after use;
testing parameters: visia CR is used for acquiring facial images; primos is used for facial image acquisition and skin wrinkle analysis; 3. skin moisture tester
CM 825 is used for detecting the moisture content of stratum corneum; the Visioscan VC98 is used for carrying out facial image acquisition and skin texture analysis; 5. skin elasticity tester
MPA580 is used to detect skin elasticity; 6. skin water loss tester
TM300 is used for detecting the transepidermal water loss rate of the skin; 7. volunteers assessed themselves.
Before use: the volunteers clean the face, wait for 30min in a laboratory at the temperature of 21 +/-1 ℃ and the relative humidity of 50 +/-5 percent, collect facial images and test the moisture content of the stratum corneum, the elasticity of the skin and the water loss rate of the skin through the epidermis.
After 14 days of use: cleaning face of volunteer, waiting for 30min in laboratory at 21 + -1 deg.C and 50 + -5% relative humidity, collecting facial image, and testing stratum corneum water content, skin elasticity, and skin transepidermal water loss rate.
After 28 days of use: cleaning the face of a volunteer, waiting for 30min in a laboratory at the temperature of 21 +/-1 ℃ and the relative humidity of 50 +/-5%, carrying out facial image acquisition, testing the moisture content of the stratum corneum, the elasticity of the skin and the water loss rate of the skin through epidermis, and carrying out self-evaluation.
And (3) data statistics: data were counted using SPSS19.0 and compared using paired T-test with significance difference levels all P < 0.05.
Compared with the prior use, the experimental results are as follows;
1) skin wrinkles: after 14 days of use, the Ra value of skin wrinkles in the tested area was significantly reduced by 5.72%, the number of skin wrinkles was significantly reduced by 7.50%, the mean volume value of skin wrinkles was not significantly reduced by 8.28%, the mean area value of skin wrinkles was significantly reduced by 8.33%, and the mean length value of skin wrinkles was significantly reduced by 16.14%; after 28 days of use, the Ra value of skin wrinkles in the tested area was significantly reduced by 8.49%, the number of skin wrinkles was significantly reduced by 10.00%, the mean volume value of skin wrinkles was not significantly reduced by 5.03%, the mean area value of skin wrinkles was significantly reduced by 11.75%, and the mean length value of skin wrinkles was significantly reduced by 22.44%.
2) Moisture content of skin stratum corneum: after 14 days of use, the moisture content value of the stratum corneum of the tested area is remarkably increased by 28.64 percent; after 28 days of use, the moisture content of the stratum corneum in the test area was significantly increased by 34.33%.
3) Skin texture: after 14 days of use, the skin roughness value of the tested area is significantly reduced by 12.42%, and the skin smoothness value is not significantly increased by 0.62%; after 28 days of use, there was a significant reduction in skin roughness by 13.15% in the test area and no significant increase in skin smoothness value by 0.01%.
4) Skin elasticity: after 14 days of use, the R2 value for skin elasticity in the test area increased significantly by 7.98%; after 28 days of use, the R2 value for skin elasticity in the test area increased significantly by 8.19%.
5) Skin transepidermal water loss rate: after 14 days of use, the value of the transepidermal water loss of the skin in the tested area is significantly reduced by 11.27 percent; after 28 days of use, the transepidermal water loss rate of the skin in the test area was significantly reduced by 20.78%.
6) Self-assessment of volunteers: after 28 days of use, 94% of the volunteers were satisfied with the effect of the test sample, 94% of the volunteers were willing to continue using the test sample after the test was finished, 97% of the volunteers were willing to purchase the test sample without considering the price, and 100% of the volunteers considered to recommend the test sample to others.
7) Adverse reactions: during the use of the samples, 0 volunteers had local or systemic adverse skin reactions.
From the above results, it can be seen that the active composition for external anti-aging skin preparations of the present invention has a good anti-aging effect, and can significantly reduce skin wrinkles, increase the moisture content of the stratum corneum of the skin, reduce pachylosis, smooth the skin, increase the elasticity of the skin, reduce transepidermal water loss, and provide volunteers with satisfactory use effects without adverse reactions to the skin.
Finally, it should be noted that: the above embodiments are only used to illustrate the technical solution of the present invention, and not to limit the same; while the invention has been described in detail and with reference to the foregoing embodiments, it will be understood by those skilled in the art that: the technical solutions described in the foregoing embodiments may still be modified, or some or all of the technical features may be equivalently replaced; and the modifications or the substitutions do not make the essence of the corresponding technical solutions depart from the scope of the technical solutions of the embodiments of the present invention.
Claims (13)
1. A cosmetic composition is characterized by comprising the following components in percentage by mass;
25% -35% of the component A and 65% -75% of the component B;
the component A comprises the following components in percentage by mass:
10-20% of bidens plant extract, 10-15% of lecithin, 40-60% of glycerol, 10-15% of caprylic/capric triglyceride, 1-10% of palm oil, 1-10% of grass cotton seed oil and 1-5% of linseed oil;
the component B comprises mother-of-pearl leavening; the mother-of-pearl fermentation product is mainly prepared by fermenting strains and mother-of-pearl;
the preparation method of the mother-of-pearl fermentation product comprises the following steps:
inoculating the strain into the mixture of the crushed nacre and the fermentation liquid culture medium, and performing fermentation culture;
the addition amount of the crushed nacre is 0.01-10% of the mass of the fermentation liquid culture medium;
the culture temperature is 27.8-28.2 ℃, and the culture time is 4-6 days;
the culture is shaking culture, and the rotating speed of the culture is 115-125 rpm.
2. The cosmetic composition according to claim 1, wherein the component A further comprises 0.1 to 10 mass% of water.
3. The cosmetic composition of claim 1, wherein said plant of the genus Bidens is selected from at least one of Bidens pilosa, Bidens salicifolia, Bidens tripartita, and Bidens alba.
4. The cosmetic composition according to claim 1, wherein the bacterial species is at least one selected from the group consisting of yeast, aureobasidium pullulans and lactobacillus.
5. The cosmetic composition according to claim 1, wherein the mother-of-pearl fermentation product contains 30 to 300mg/L of polysaccharide and 10 to 200mg/L of calcium ion.
6. The cosmetic composition of claim 1, wherein said nacre is selected from at least one of the group consisting of queen phoenix, hyriopsis cumingii, crista plicata, and pearl oyster mazel.
7. A process for the preparation of a cosmetic composition according to any one of claims 1 to 6, comprising the steps of:
and uniformly mixing the component A and the component B.
8. The method for preparing a cosmetic composition according to claim 7, wherein the component A is prepared by the method comprising the steps of:
adding lecithin into mixture of Bidens plant extract, caprylic/capric triglyceride, semen gossypii oil, oleum Lini and palm oil, heating, adding glycerol and water, homogenizing, and cooling.
9. An anti-aging cosmetic comprising the cosmetic composition according to any one of claims 1 to 6.
10. The anti-aging cosmetic as claimed in claim 9, wherein the amount of the cosmetic composition is 0.001-10% by mass of the total mass of the anti-aging cosmetic.
11. The anti-aging cosmetic as claimed in claim 10, wherein the amount of the cosmetic composition is 0.01 to 5% by mass of the total mass of the anti-aging cosmetic.
12. The anti-aging cosmetic of claim 9, wherein the anti-aging cosmetic comprises serum.
13. The anti-aging cosmetic according to claim 12, wherein the essence is mainly prepared from the following components in percentage by mass:
0.1-2% of sodium polyacryloyl dimethyl taurate, 0.5-5% of diglycerol, 1-10% of glycerol, 0.5-5% of betaine, 0.1-4% of hydroxyethyl piperazine ethane sulfonic acid, 0.01-1% of acetylated sodium hyaluronate, 0.01-0.5% of inulin lauryl carbamate, 0.1-2% of octyldodecanol, 0.2-10% of polydimethylsiloxane, 0.1-10% of the cosmetic composition, 0.1-0.5% of p-hydroxyacetophenone, 0.1-0.5% of phenoxyethanol, 0.01-0.02% of essence and the balance of water.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110320424.6A CN112972361B (en) | 2021-03-25 | 2021-03-25 | Composition, preparation method thereof and anti-aging cosmetic |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110320424.6A CN112972361B (en) | 2021-03-25 | 2021-03-25 | Composition, preparation method thereof and anti-aging cosmetic |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN112972361A CN112972361A (en) | 2021-06-18 |
| CN112972361B true CN112972361B (en) | 2022-03-25 |
Family
ID=76333614
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110320424.6A Active CN112972361B (en) | 2021-03-25 | 2021-03-25 | Composition, preparation method thereof and anti-aging cosmetic |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112972361B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113384513B (en) * | 2021-07-08 | 2022-06-28 | 广州市尚梓化工科技有限公司 | Preparation method of yeast fermentation product filtrate and application of yeast fermentation product filtrate in cosmetics |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1686082A (en) * | 2005-03-23 | 2005-10-26 | 北海东方创美生物工程有限责任公司 | Pearl skin care liquid and its preparation method |
| US20150182444A1 (en) * | 2013-12-31 | 2015-07-02 | Shang Chen Mei Bang (Beijing) Biotechnology Co., Ltd. | Traditional chinese medicine composition for anti-wrinkle |
| CN104706567B (en) * | 2015-03-31 | 2017-08-01 | 广西还珠海洋生物科技有限公司 | The method and product of pearl foetal sac liquid are extracted in a kind of pearl foetal sac from mother pearl shellfish |
| JP7338842B2 (en) * | 2018-10-19 | 2023-09-05 | 丸善製薬株式会社 | wrinkle-improving composition and wrinkle-improving skin cosmetic |
| CN110897961A (en) * | 2019-12-23 | 2020-03-24 | 安徽云指智数据科技有限公司 | Birchleaf pear flower compound antioxidant beautifying toner and preparation method thereof |
| CN111544372A (en) * | 2020-06-15 | 2020-08-18 | 溯源生命科技股份有限公司 | Fermentation product compound plant extract anti-aging repair composition, application and essence milk containing composition |
-
2021
- 2021-03-25 CN CN202110320424.6A patent/CN112972361B/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN112972361A (en) | 2021-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021020887A (en) | Enhanced anti-aging cosmetic composition | |
| CN112494403B (en) | Oat fermentation liquor and preparation method and application thereof | |
| CN110279599B (en) | Whitening composition, set containing whitening composition and preparation method of set | |
| CN108836919B (en) | Moisturizing cosmetic composition and preparation method and application thereof | |
| CN110585076A (en) | Prebiotics and probiotic composition, and preparation method and application thereof | |
| CN114632055B (en) | Whitening and relieving plant fermentation product and preparation method and application thereof | |
| CN115554220B (en) | Microbial fermentation stock solution with skin care effect and preparation method and application thereof | |
| CN108815072A (en) | A kind of plant composition fermentation magma and its preparation method and application | |
| CN113456569A (en) | Skin elastic repairing and moisturizing mask and preparation method thereof | |
| CN114569536A (en) | A lotion for improving microecology and physiological state of aged skin | |
| CN115463048A (en) | Acne-removing face-refreshing essence and preparation method thereof | |
| CN112972361B (en) | Composition, preparation method thereof and anti-aging cosmetic | |
| CN109172433B (en) | Long-acting moisturizing composition and application thereof in cosmetics | |
| CN113101256B (en) | Anti-aging repair nanoemulsion and application thereof | |
| CN111904909B (en) | Dandruff removing scalp essence containing rose fermentation liquor and preparation method thereof | |
| CN111904908A (en) | Essence containing rose fermentation liquor and preparation method thereof | |
| CN116377009A (en) | Ginsenoside extract and preparation method and application thereof | |
| US11925701B2 (en) | Method for skin conditioning by using Dan Feng peony extract | |
| CN113081924B (en) | Antioxidant composition, preparation method and application | |
| KR101806007B1 (en) | Manufacturing method of cosmetic composition containing nano particle natural materials and cosmetic composition manufactured by the same | |
| CN113244140A (en) | Composition for regulating skin micro-ecological balance and application and preparation method thereof | |
| CN110960464A (en) | Anti-wrinkle eye cream containing plant source fermentation extract and preparation method thereof | |
| CN113384483A (en) | Composition for improving skin elasticity and delaying aging and preparation method thereof | |
| CN115381762B (en) | Preparation method of snail fermentation filtrate, composition containing snail fermentation filtrate and application of snail fermentation filtrate | |
| CN115364036B (en) | Composition containing snail fermentation filtrate and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Composition, preparation method and anti-aging cosmetics Granted publication date: 20220325 Pledgee: Agricultural Bank of China Limited Deqing County sub branch Pledgor: OSMUN BIOLOGICAL Co.,Ltd. Registration number: Y2024980023335 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right |